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Abstract 
Inflammatory bowel disease (IBD) is a multisystem disorder with gastrointestinal tract involvement. These pa-
tients have the higher risk for thromboembolic events compared to normal population. This report describes a 
unique case of pulmonary embolism as a first manifestation of inflammatory bowel disease. 
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nflammatory bowel disease (IBD) is a multisystem dis-
order with gastrointestinal tract involvement. This dis-
ease is usually characterized by specific features like 
chronic or nocturnal diarrhea, abdominal pain, weight loss, 
fever and rectal bleeding. This disease can correlate with 
systemic and extra-intestinal complications (1). Elevated 
thrombin–antithrombin complexes, prothrombin frag-
ments, and D-dimer levels and their increases with disease 
activity are other evidence pointing toward the relation be-
tween inflammation and coagulation. These factors lead to 
higher risk of thromboembolic events in IBD patients com-
pared to normal population (2-4). The incidence of sys-
temic thromboembolic events in IBD ranges from 1%–
7.7% and 39%–41% in clinical and postmortem studies, re-
spectively. Similar to other patients, deep vein thrombosis 
(DVT) and/or pulmonary thromboembolism (PTE) are the 
most common thrombotic events. Cerebral, portal, mesen-
teric, and retinal veins thrombosis have fewer occurrences 
(5). These events are associated with increased risk of mor-
tality and require improved awareness and prevention (6). 
This report describes a unique case of pulmonary embo-
lism as a first manifestation of inflammatory bowel disease.  
 
Case report: 
A 46-year-old female was referred to t department with 
pain and edema of her right leg. She was a known case of 
hypertension and hyperlipidemia and had a history of 
left leg DVT about two years ago. In previous admission 
she was discharged on warfarin but after few months of 
treatment, warfarin had been stopped due to active pep-
tic ulcer disease. Collagen vascular markers such as anti-
nuclear antibody (ANA), anti-double stranded DNA 
(anti-dsDNA), anticardiolipin and lupus anticoagulant 
antibodies were negative in first admission which were 
requested due to recurrent abortions (three times) in 
her past medical history. Doppler ultrasound was per-
formed to evaluate her leg pain and edema. Findings re-
vealed popliteal and superficial femoral vein thrombosis. 
I 
 
Figure 1: Chest computed tomography angiography of patient, 
arrow pointed the location of embolus in the right main pulmo-
nary artery. 
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She was admitted again and anticoagulant therapy was 
started. During her admission, dyspnea was developed; 
so pulmonary computed tomography angiography 
(CTA) was performed and pulmonary emboli was 
demonstrated (Figure 1). In addition to dyspnea she was 
complaining of abdominal pain and non-bloody diar-
rhea. Thrombosis of intra-abdominal vessels was ruled 
out with magnetic resonance venography (MRV). Since 
her abdominal pain was resistant to analgesics and she 
had a past surgical history of appendectomy, abdominal 
CT scan was performed which showed sub-mucosal 
bleeding and thickness of jejunum indicating probable 
IBD diagnosis. The patient underwent colonoscopy due 
to abdominal pain, past medical history, intermittent 
non-bloody diarrhea, and abdominal CT findings. Unex-
pectedly, patchy ulceration was seen coincident of IBD 
(Figure 2). The patient was treated by intravenous un-
fractionated heparin and discharged on warfarin. Follow 
up in out-patient clinic for international normalized ra-




Venous thromboembolism incidence differs from 1.3% 
to 6.2 % and has a mortality rate of 8% to 25% in IBD 
population. Most of thromboembolic events occur in IBD 
patients who are younger than 50 and is more common 
in females compared to males (7). Like IBD pathogene-
sis, the mechanism of hypercoagulability state is not fully 
understood. Despite the role of inflammation in activa-
tion of coagulation cascade, it seems that this higher in-
cidence rate of thrombosis in IBD is not linked to inflam-
matory process and evidence in literature has been con-
sidered IBD as an independent risk factor for thrombo-
embolism (table 1) (8, 9). Some studies have implicated 
platelet activation by endothelial dysfunction and hyper-
homocysteinemia activation of the coagulation cascade 
(10). Inherited causes of thrombophilia such as factor V 
Leiden mutation, prothrombin gene mutation, inherited 
hyperhomocysteinemia, MTHFR gene polymorphism, 
deficiency of protein C and S, antithrombin III mutation 
does not associate with thrombotic events in patients 
with IBD. For patients who are diagnosed with venous 
thromboembolism (VTE), work-up is often necessary to 
indicate the underlying cause. The first diagnostic steps 
are rectal examination, fecal occult blood testing and co-
lonoscopy to rule out malignancy which is a strong risk 
factor for VTE. In absence of inherited causes,  acquired 
one may play a crucial role, but all of them including pro-
longed immobilization, surgery, fluid depletion, steroid 
therapy, central venous catheters, smoking and oral con-
traceptive were absent in our patient (4, 11-13). Bleed-
ing tendency makes the treatment of these patients so 
difficult. Heparin has been implicated in the therapeutic 
management of ulcerative colitis with thromboembo-
lism. Two studies showed controversial role for heparin. 
One of them revealed benefits of use but another failed 
to repeat this finding and was associated with increased 
risk of bleeding. Evidence is not enough to utilize low 
molecular weight heparin. Thrombolytic agents can be 
life saver in IBD patient with massive PTE. Cardiogenic 
shock and/or right ventricular dysfunction are the main 
indication of administration. Vitamin k antagonists 
should be used with caution due to risk of causing large 
hemorrhage. Considering above; management of these 
patients needs multi specialist consultation (14). Based 
on new consensus, testing for hereditary or acquired hy-
percoagulability states is not necessary in IBD patients 
with VTE. In the absence of another provoking factor in 
clinical remission state of IBD, anticoagulant therapy at 
least for 3 months has been recommended with periodic 
reevaluation. There is no recommended follow up time 
for these patients but based on new consensus echocar-
diography and CTA can be repeated for reevaluation of 
anti-coagulation therapy. It seems that persistent use of 
anticoagulant is not obligatory in patients with good 
right ventricular function or no evidence of PTE in men-
tioned investigations (15). However, there is no differ-
ence between the management of an acute thrombotic 
event in patients with IBD and other patients. Patients 
with diagnosis of PTE need electrocardiography and 
echocardiography evaluation. In patients with massive 
saddle emboli, evidence of right heart strain or hyper-
tension is an independent predictor of mortality.  Hence, 
thrombolysis should be considered. Currently, there is 
no preferred medication and low-molecular-weight hep-
arin (LMWH) or un-fractionated heparin (UFH) have 
equal effects (16). 
 
Conclusion: 
Inflammation and coagulation have been implicated in 
the pathogenesis of numerous diseases like IBD. Imbal-
ance between prothrombotic and protective mecha-
nisms leads to thrombosis and pathologic blood coagula-
tion. Therefore, finding and treatment of probable un-
derline causes of thrombosis should be considered in all 
VTE patients referred to the emergency department. 
 
Figure 2: Colonoscopy views of patient’s sigmoid (left) and 
rectum (right), arrow pointed to location of patchy ulceration 
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